665 A PHASE I/II STUDY OF FORETINIB, AN ORAL MULTIKINASE INHIBITOR TARGETING MET, RON, AXL, TIE-2 AND VEGFR IN ADVANCED HEPATOCELLULAR CARCINOMA (HCC)T. Yau,C.-J. Yen,P.-J. Chen,Y. Chau,R. Lencioni,H. Kallender,L.H. Ottesen,R.T.-P. PoonJournal of Hepatology（2011）引用 26|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
